GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kazia Therapeutics Ltd (FRA:NV9M) » Definitions » Balance Sheet Cash And Cash Equivalents

Kazia Therapeutics (FRA:NV9M) Balance Sheet Cash And Cash Equivalents


View and export this data going back to . Start your Free Trial

What is Kazia Therapeutics Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Kazia Therapeutics (FRA:NV9M) Business Description

Industry
Traded in Other Exchanges
Address
300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.